SynthesisHeart failure reviews2022

SGLT2 inhibitors and cardiovascular and renal outcomes: a meta-analysis and trial sequential analysis.

Mahmoud Barbarawi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.